Headline

The latest stories from AHA Today.

The AHA today named Chris DeRienzo, M.D., senior vice president and chief physician executive. In his new role, DeRienzo will develop strategies and resources that improve health outcomes in support of the mission of the nation’s hospitals and health systems.
The AHA Committee on Nominations is accepting nominations for chair-elect of the Board of Trustees and five at-large trustees for three-year terms beginning Jan. 1, 2024.
The Federal Emergency Management Agency deadline is Dec. 31 for applicants to submit funding requests and related documentation to the Public Assistance program at the 100% Federal cost share for COVID-19 emergency work activities performed through July 1, 2022.
International Hospital Federation leaders recently briefed the World Health Organization on its Geneva Sustainability Centre, launched this year with support from University Hospitals of Geneva to help hospital and health system leaders advance environmentally sustainable and climate-resilient…
The Healthcare Cyber Communications Center, FBI, Cybersecurity & Infrastructure Security Agency and National Security Agency in December warned of new ransomware strains and other cyber threats targeting health care.  
The Department of Homeland Security Dec. 19 released policy guidance for the Public Charge Ground of Inadmissibility final rule.
The Department of Health and Human Services today released on the Centers for Medicare & Medicaid Services website detailed information on the ownership of more than 7,000 hospitals certified to participate in the Medicare program.
The Joint Commission announced plans to revise 56 standards during the first review cycle of 2023 according to an article in Modern Healthcare.
The House and Senate  Appropriations Committees last night released the fiscal year 2023 Omnibus Appropriations legislation that would fund the government through Sept. 30, 2023. The bipartisan bill includes various provisions beneficial to hospitals and health systems.  
The U.S. Food & Drug Administration has issued a Class I recall, the most serious type of recall, for the Arrow MAC Two-Lumen Central Venous Access Kits and Arrow Pressure Injectable Arrowg+ard Blue Plus Three-Lumen Central Venous Catheter Kits.